DNA Group TR Ltd (DNA)

Currency in ILS
109.2
-1.9(-1.71%)
Closed·
DNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
DNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
107.0112.0
52 wk Range
59.0121.8
Key Statistics
Bid/Ask
110.20 / 111.20
Prev. Close
111.1
Open
112
Day's Range
107-112
52 wk Range
59-121.8
Volume
175.4K
Average Volume (3m)
325.62K
1-Year Change
65.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

DNA Group TR Ltd Company Profile

Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.

Compare DNA to Peers and Sector

Metrics to compare
DNA
Peers
Sector
Relationship
P/E Ratio
6.1x12.7x11.8x
PEG Ratio
0.000.420.01
Price/Book
1.3x1.8x2.4x
Price / LTM Sales
439.5x1.5x2.2x
Upside (Analyst Target)
-20.4%19.1%
Fair Value Upside
Unlock8.5%5.8%Unlock

Earnings

Latest Release
Mar 13, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
153.00K / --
EPS Revisions
Last 90 days

DNA Income Statement

FAQ

What Stock Exchange Does DNA Group TR Trade On?

DNA Group TR is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for DNA Group TR?

The stock symbol for DNA Group TR is "DNA."

What Is the DNA Group TR Market Cap?

As of today, DNA Group TR market cap is 134.50M.

What Is DNA Group TR's Earnings Per Share (TTM)?

The DNA Group TR EPS (TTM) is 0.18.

From a Technical Analysis Perspective, Is DNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has DNA Group TR Stock Split?

DNA Group TR has split 2 times.

How Many Employees Does DNA Group TR Have?

DNA Group TR has 0 employees.

What is the current trading status of DNA Group TR (DNA)?

As of 31 Jul 2025, DNA Group TR (DNA) is trading at a price of 109.20, with a previous close of 111.10. The stock has fluctuated within a day range of 107.00 to 112.00, while its 52-week range spans from 59.00 to 121.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.